Clinical Trials Directory

Trials / Sponsors / Janssen-Cilag G.m.b.H

Janssen-Cilag G.m.b.H

Industry · 11 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
RecruitingA Study to Generate Real-world Evidence of Guselkumab Effectiveness in Inflammatory Bowel Disease in Germany
Inflammatory Bowel Disease, Colitis, Ulcerative, Crohn's Disease
—2025-08-18
CompletedA Study to Compare the Efficacy of Guselkumab to Fumaric Acid Esters for the Treatment of Participants With Mo
Psoriasis
Phase 32016-12-12
CompletedHuman Immunodeficiency Virus (HIV) Postexposure Prophylaxis (PEP) With Darunavir/Ritonavir (DRV/r)
Human Immunodeficiency Virus (HIV)
Phase 32011-11-25
TerminatedA Positron-Emission-Tomography (PET) Study to Measure the Blockade of Dopamine Receptors (D2) in Specific Area
Schizophrenia
Phase 42009-09-01
CompletedStudy of Bortezomib and Dexamethasone With or Without Cyclophosphamide in Patients With Relapsed or Not Contro
Multiple Myeloma
Phase 32009-01-01
TerminatedA Study to Evaluate the Safety and Tolerability of Fentanyl Iontophoretic Transdermal System (Fentanyl-ITS) in
Postoperative Pain
Phase 42008-03-01
CompletedA Study of Bortezomib as Consolidation Therapy in Patients With Multiple Myeloma
Multiple Myeloma
Phase 32006-12-01
CompletedConsolidation Therapy With Bortezomib in Elderly Patients With Multiple Myeloma
Multiple Myeloma
Phase 32006-10-01
CompletedA Study of Bortezomib, Cyclophosphamide, and Dexamethasone in Patients With Untreated Multiple Myeloma and Pla
Multiple Myeloma
Phase 22006-03-01
CompletedLong-term Use of Galantamine Versus Nootropics (Memory Enhancing Drugs) in Patients With Alzheimer's Dementia
Dementia, Alzheimer Disease, Dementia, Vascular
—2006-03-01
TerminatedAn Efficacy and Tolerability Study of Bortezomib in Combination With Rituximab Standard Therapy in Participant
Lymphoma, Follicular
Phase 22006-02-01